Clinical Trial Update: Universal CAR-T Cell Therapy for NHL [NA]

View source ↗

Summary

Recruitment is ongoing for a universal CAR-T cell therapy being studied in non-Hodgkin lymphoma (B-cell subtype), sponsored by Bioray Laboratories.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Universal CAR-T Cell Therapy

Snippet

Sponsor: Bioray Laboratories | Conditions: Non-hodgkin Lymphoma,B Cell | NA | Status: RECRUITING